This page has been validated.
S 992/2021
12
- (ii) the individual’s test result shows the presence of SARS-CoV-2 in that individual and that is not an atypical finding for SARS-CoV-2; or
- (b) the Director of Medical Services or Deputy Director of Medical Services is satisfied that it is the interest of the health and safety of the individual to do so.
(5) In this regulation—
- “approved test provider”, “atypical finding for SARS-CoV-2” and “recognised medical practitioner” have the meanings given by the Infectious Diseases (COVID-19 Access Restrictions and Clearance) Regulations 2021;
- “relevant sampling activity” means removing a respiratory specimen from the lining of the oral or nasal passages of an individual where that is being done for the purpose of subjecting the respiratory specimen to an approved test for the purpose of testing the presence of SARS-CoV-2 in that individual;
- “test result is treated as negative for SARS-CoV-2” has the meaning given by regulation 8 of the Infectious Diseases (COVID-19 Access Restrictions and Clearance) Regulations 2021.
PART 2
WORK-FROM-HOME ARRANGEMENTS
Work-from-home arrangements for employees
6.—(1) Subject to regulation 7, an employer must not cause or allow any employee of the employer to attend at any of the work premises of the employer to perform work for the employer when not on leave if it is reasonably practicable for the employee to perform that work for the employer at the employee’s place of residence.
(2) An employer must provide the tools, equipment, materials and other facilities necessary for an employee of the employer to perform work in the employee’s place of residence—
